Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy.

Huiqin Yang, Shiqiang Li, Xueshan Xiao, Panfeng Wang, Xiangming Guo, Qingjiong ZhangPubMed Central 2012

TL;DR

This study investigates the genetic underpinnings of Familial Exudative Vitreoretinopathy (FEVR) in Chinese families, identifying mutations in the FZD4 and LRP5 genes in 22.4% of the studied cohort. The findings highlight the genetic heterogeneity of FEVR and the significant variability in its clinical presentation, even within families carrying the same mutation.

What Problem Does This Paper Address?

Familial Exudative Vitreoretinopathy (FEVR) is a hereditary disorder affecting the development of retinal blood vessels, potentially leading to severe vision impairment or blindness. While several genes (FZD4, LRP5, TSPAN12, and NDP) have been implicated in FEVR, particularly those involved in the Wnt signaling pathway, studies focusing on the Chinese population have been limited. This paper aims to fill that gap by identifying the mutation spectrum and frequency of FZD4 and LRP5 in Chinese families with FEVR, contributing to a better understanding of the genetic causes of this condition in this demographic.

Methods

The researchers collected clinical data and genomic DNA from 49 Chinese families diagnosed with FEVR. They employed standard molecular biology techniques:

  • Polymerase Chain Reaction (PCR): Used to amplify the coding exons and adjacent intronic regions of the FZD4 and LRP5 genes. A "touchdown" PCR protocol was utilized, starting with a higher annealing temperature and gradually decreasing it to optimize amplification specificity.
  • Sanger Sequencing: The amplified DNA fragments were then sequenced using Sanger sequencing to detect any variations.
  • Bioinformatic Analysis: Sequences were aligned with human genome databases (NCBI) using the SeqManII program.
  • Mutation Assessment: Missense mutations were further analyzed using computational tools like Blosum62 and PolyPhen to predict their potential functional impact and evolutionary conservation.

TSPAN12 mutations were excluded from this study as they had been previously analyzed in the same cohort.

Datasets

The study utilized:

  • 49 Chinese families with FEVR: This cohort served as the primary dataset for mutation screening.
  • 192 chromosomes from 96 normal controls: These were used to confirm that identified mutations were not common polymorphisms.

No new benchmark datasets were introduced in this paper.

Key Insights and Ideas

  • Significant Genetic Contribution of FZD4 and LRP5: The study confirms that FZD4 and LRP5 are important genetic contributors to FEVR in the Chinese population, accounting for a substantial portion of the identified mutations.
  • High Novelty Rate: A significant proportion (8 out of 11) of the identified mutations were novel, underscoring the ongoing discovery of genetic variations associated with FEVR.
  • Phenotypic Variability: The paper emphasizes the considerable variability in clinical presentation, even among individuals within the same family or those carrying the same mutation. This highlights the complexity of FEVR and suggests that other genetic or environmental factors might influence disease severity.
  • Importance of Computational Prediction: The use of tools like Blosum62 and PolyPhen aids in prioritizing potentially deleterious mutations, especially for missense variants.

Key Results

  • Mutation Detection Rate: Mutations in FZD4 and LRP5 were identified in 11 out of 49 families (22.4%).
  • Gene Distribution: Five FZD4 mutations were found in six families, and six LRP5 mutations were found in five families.
  • Novelty: Eight of the eleven identified mutations were novel.
  • Compound Heterozygosity: One family exhibited compound heterozygous mutations in LRP5.
  • Phenotypic Correlation: While all affected individuals showed FEVR-related ocular changes, the specific manifestations varied widely, ranging from asymptomatic to severe vision loss.

Limitations and Future Work

  • Incomplete Genetic Coverage: The study acknowledges that a significant proportion of families (73.1%) did not have detectable mutations in FZD4 or LRP5. This suggests that other genes involved in FEVR, or mutations in non-coding regions of these genes, may be responsible.
  • Limited Scope: The study focused only on FZD4 and LRP5. While TSPAN12 and NDP were previously excluded, the possibility of mutations in other FEVR-related genes remains.
  • Future Directions: The authors suggest that future research should focus on:
  • Investigating mutations in intronic or regulatory regions of known FEVR genes.
  • Exploring additional genes involved in the Wnt/Norrin signaling pathway.
  • Utilizing next-generation sequencing and exome sequencing to identify novel FEVR genes in families where mutations remain undetected.

Summary updated

Abstract

PURPOSE: To identify mutations in FZD4 and LRP5 in 49 Chinese families with familial exudative vitreoretinopathy (FEVR) and to reveal the mutation spectrum and frequency of these genes in the Chinese population. METHODS: Clinical data and genomic DNA were collected for patients from 49 families with FEVR. The coding exons and adjacent intronic regions of FZD4 and LRP5 were amplified with polymerase chain reaction, and the resulting amplicons were analyzed with Sanger sequencing. RESULTS: Eleven mutations were detected in 11 of the 49 families (22.4%), including five mutations in the FZD4 gene in six families and six mutations in the LRP5 gene in five families. Of the 11 mutations, eight were novel. Two families had the same FZD4 mutation, and one family had compound heterozygous mutations in LRP5. The phenotypes of the patients with the mutations showed great variability. CONCLUSIONS: Our findings provide an overview of the mutation spectrum and frequency of FZD4 and LRP5 in Chinese patients with FEVR and emphasize the complexity of FEVR mutations and phenotypes.
BibTeX
@inproceedings{yang2012identification,
  author = {Huiqin Yang and Shiqiang Li and Xueshan Xiao and Panfeng Wang and Xiangming Guo and Qingjiong Zhang},
  title = {{Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy.}},
  booktitle = {PubMed Central},
  year = {2012},
}
Figure